BOLT vs AAPL: Which Stock is Better?
Side-by-side comparison of Bolt Biotherapeutics and Apple Inc in 2026
BOLT
Bolt Biotherapeutics
$4.07
AAPL
Apple Inc
$326.67
Key Metrics Comparison
| Metric | BOLT | AAPL | Winner |
|---|---|---|---|
| Market Cap | $11.33M | $3.83T | AAPL |
| P/E Ratio | N/A | 34.84 | BOLT |
| EPS (TTM) | $N/A | $7.47 | AAPL |
| Revenue Growth | 90.1% | 7.9% | BOLT |
| Gross Margin | 0.0% | 46.9% | AAPL |
Analyze BOLT
Full quant analysis
Analyze AAPL
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is BOLT or AAPL a better investment?
Comparing BOLT and AAPL: Bolt Biotherapeutics has a market cap of $11.33M while Apple Inc has $3.83T. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between BOLT and AAPL?
BOLT (Bolt Biotherapeutics) and AAPL (Apple Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: BOLT or AAPL?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: BOLT or AAPL?
BOLT has higher revenue growth at 90.1% vs 7.9% for AAPL.
Which company is more profitable: BOLT or AAPL?
Apple Inc (AAPL) has higher gross margins at 46.9% compared to 0.0% for BOLT.
Which is the larger company: BOLT or AAPL?
Apple Inc (AAPL) is larger with a market cap of $3.83T compared to $11.33M for BOLT.
Should I buy BOLT or AAPL in 2026?
Both BOLT and AAPL have investment merit. BOLT trades at $4.07 while AAPL trades at $326.67. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between BOLT and AAPL stock?
Key differences: Market Cap ($11.33M vs $3.83T), P/E Ratio (N/A vs 34.8x), Revenue Growth (90.1% vs 7.9%), Gross Margin (0.0% vs 46.9%).
Should I buy BOLT or AAPL in 2026?
The choice between BOLT and AAPL depends on your investment goals. BOLT shows higher revenue growth (90.1%). AAPL has better margins (46.9%). Consider your risk tolerance and time horizon.
What is the market cap comparison between BOLT and AAPL?
BOLT (Bolt Biotherapeutics) has a market cap of $11.33M, while AAPL (Apple Inc) has a market cap of $3.83T. AAPL is the larger company by market value.